Breaking News Instant updates and real-time market news.

GMAB

Genmab

$38.19 /

-0.34 (-0.88%)

, JNJ

Johnson & Johnson

$144.18 /

-0.87 (-0.60%)

17:06
09/22/20
09/22
17:06
09/22/20
17:06

Genmab commences arbitration of two matters under license agreement with Janssen

Genmab (GMAB) announced that it has commenced binding arbitration of two matters arising under its license agreement with Janssen Biotech (JNJ) relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab. The arbitration first is to settle whether Genmab is required to share in Janssen's royalty payments to Halozyme Therapeutics, Inc. for the Halozyme enzyme technology used in the subcutaneous formulation of daratumumab. The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of subcutaneous daratumumab sales. Janssen has started reducing its royalty payments to Genmab by what it claims to be Genmab's share of Janssen's royalty payments to Halozyme for the second quarter of 2020. The arbitration is also to settle whether Janssen's obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement. The relevant Genmab-owned issued U.S., European and Japanese patents will expire in the late 2020s and early 2030s. The relevant Janssen-owned issued patents and patent applications (if granted) covering the subcutaneous formulation of daratumumab would expire in the mid-2030s. Under the agreement, the arbitration will be conducted in New York pursuant to the rules of the CPR Institute for Dispute Resolution for Non-Administered Arbitration before a panel of three arbitrators. While Genmab intends to vigorously protect its rights under the agreement, the outcome of any arbitration proceeding, as well as its duration, is inherently uncertain. The arbitration will be confidential, subject to the parties' disclosure obligations under applicable law. Other than pursuant to these obligations, Genmab does not intend to comment or provide additional information regarding the arbitration until an order on the merits or other material order is issued in the arbitration or the arbitration is otherwise concluded. While the arbitration is pending, Genmab's collaborations with Janssen on daratumumab and HexaBody-CD38 will continue. Based on currently available information, Genmab does not expect these matters to materially affect its 2020 financial guidance.

GMAB

Genmab

$38.19 /

-0.34 (-0.88%)

JNJ

Johnson & Johnson

$144.18 /

-0.87 (-0.60%)

  • 13

    Oct

GMAB Genmab
$38.19 /

-0.34 (-0.88%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
09/08/20 SVB Leerink
Genmab initiated with a Market Perform at SVB Leerink
08/24/20 Truist
Genmab price target raised to $41 from $39 at Truist
08/13/20 RBC Capital
Genmab price target raised to $38 from $35 at RBC Capital
JNJ Johnson & Johnson
$144.18 /

-0.87 (-0.60%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James

TODAY'S FREE FLY STORIES

Periodicals
Facebook testing miniature social network feature in Calgary, Verge reports » 12:13
10/21/20
10/21
12:13
10/21/20
12:13
FB

Facebook

$281.16 /

+13.6 (+5.08%)

Facebook said it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$281.16 /

+13.6 (+5.08%)

FB Facebook
$281.16 /

+13.6 (+5.08%)

10/20/20 Jefferies
Facebook price target raised to $320 from $310 at Jefferies
10/20/20 Credit Suisse
Facebook price target raised to $322 from $315 at Credit Suisse
10/15/20 Cowen
Trump unhappiness may reinforce odds of antitrust action on Facebook, says Cowen
10/12/20 Jefferies
Jefferies 'incrementally positive' on Facebook, Alphabet and Snap after AdWeek
FB Facebook
$281.16 /

+13.6 (+5.08%)

FB Facebook
$281.16 /

+13.6 (+5.08%)

FB Facebook
$281.16 /

+13.6 (+5.08%)

FB Facebook
$281.16 /

+13.6 (+5.08%)

Recommendations
BHP Group price target lowered to 2,210 GBp from 2,240 GBp at JPMorgan » 12:12
10/21/20
10/21
12:12
10/21/20
12:12
BBL

BHP Group

$42.32 /

+0.47 (+1.12%)

JPMorgan analyst Dominic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBL BHP Group
$42.32 /

+0.47 (+1.12%)

10/13/20 Barclays
BHP Group price target raised to 2,000 GBp from 1,950 GBp at Barclays
10/07/20 JPMorgan
BHP Group price target lowered to 2,240 GBp from 2,260 GBp at JPMorgan
09/24/20 Morgan Stanley
BHP Group price target raised to 1,700 GBp from 1,680 GBp at Morgan Stanley
09/16/20 Jefferies
Jefferies upgrades 'go-to' miner BHP to Buy
Conference/Events
Assembly Biosciences management to meet virtually with Mizuho » 12:12
10/21/20
10/21
12:12
10/21/20
12:12
ASMB

Assembly Biosciences

$15.18 /

-0.23 (-1.49%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASMB Assembly Biosciences
$15.18 /

-0.23 (-1.49%)

ASMB Assembly Biosciences
$15.18 /

-0.23 (-1.49%)

10/19/20 Truist
Assembly Biosciences initiated with a Buy at Truist
07/21/20 Baird
Assembly Biosciences HBV deal a positive, says Baird
07/20/20 Piper Sandler
BeiGene inked smart deal with Assembly, says Piper Sandler
06/02/20 Mizuho
New clinical paper potentially supports Assembly stoppage criteria, says Mizuho
ASMB Assembly Biosciences
$15.18 /

-0.23 (-1.49%)

  • 12
    Dec
Recommendations
UBS price target raised to CHF 14 from CHF 13 at JPMorgan » 12:10
10/21/20
10/21
12:10
10/21/20
12:10
UBS

UBS

$12.29 /

-0.08 (-0.65%)

JPMorgan analyst Kian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$12.29 /

-0.08 (-0.65%)

UBS UBS
$12.29 /

-0.08 (-0.65%)

11:50 Today RBC Capital
UBS price target raised to CHF 13.50 from CHF 12 at RBC Capital
11:41 Today Morgan Stanley
UBS price target raised to CHF 13 from CHF 12 at Morgan Stanley
10/19/20 Barclays
UBS price target raised to CHF 10 from CHF 9.50 at Barclays
07/24/20 Morgan Stanley
UBS price target raised to CHF 12 from CHF 11 at Morgan Stanley
UBS UBS
$12.29 /

-0.08 (-0.65%)

UBS UBS
$12.29 /

-0.08 (-0.65%)

UBS UBS
$12.29 /

-0.08 (-0.65%)

Recommendations
Remy Cointreau price target raised to EUR 116.50 from EUR 99 at JPMorgan » 12:09
10/21/20
10/21
12:09
10/21/20
12:09
REMYY

Remy Cointreau

$0.00 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$0.00 /

+ (+0.00%)

REMYY Remy Cointreau
$0.00 /

+ (+0.00%)

11:18 Today Societe Generale
Remy Cointreau price target raised to EUR 130 from EUR 112 at Societe Generale
10/09/20 Morgan Stanley
Remy Cointreau price target raised to EUR 115 from EUR 94 at Morgan Stanley
09/21/20 Barclays
Remy Cointreau price target raised to EUR 160 from EUR 155 at Barclays
07/24/20 JPMorgan
Remy Cointreau price target raised to EUR 99 from EUR 97 at JPMorgan
Recommendations
Kuehne & Nagel price target raised to CHF 176.07 from CHF 162.44 at JPMorgan » 12:08
10/21/20
10/21
12:08
10/21/20
12:08
KHNGY

Kuehne & Nagel

$0.00 /

+ (+0.00%)

JPMorgan analyst Samuel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KHNGY Kuehne & Nagel
$0.00 /

+ (+0.00%)

11:21 Today Deutsche Bank
Kuehne & Nagel price target raised to CHF 175 from CHF 165 at Deutsche Bank
05:16 Today AlphaValue
Kuehne & Nagel upgraded to Reduce from Sell at AlphaValue
10/08/20 Credit Suisse
Kuehne & Nagel price target raised to CHF 150 from CHF 135 at Credit Suisse
10/07/20 Deutsche Bank
Kuehne & Nagel price target raised to CHF 165 from CHF 140 at Deutsche Bank
Hot Stocks
WISeKey announces signing deal with Allscripts for secure communications » 12:08
10/21/20
10/21
12:08
10/21/20
12:08
WKEY

WISeKey

$6.20 /

+0.1 (+1.64%)

, MDRX

Allscripts

$11.16 /

+0.645 (+6.13%)

WISeKey (WKEY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WKEY WISeKey
$6.20 /

+0.1 (+1.64%)

MDRX Allscripts
$11.16 /

+0.645 (+6.13%)

WKEY WISeKey
$6.20 /

+0.1 (+1.64%)

09/09/20 H.C. Wainwright
WISeKey price target raised to $9 from $6 at H.C. Wainwright
MDRX Allscripts
$11.16 /

+0.645 (+6.13%)

10/19/20 Baird
Baird calls Allscripts "classic value trap", downgrades to Neutral
10/19/20 Baird
Allscripts downgraded to Neutral from Outperform at Baird
10/14/20 Piper Sandler
Allscripts selling everything investors want to own, says Piper Sandler
07/21/20 Goldman Sachs
Allscripts downgraded to Sell from Neutral at Goldman Sachs
MDRX Allscripts
$11.16 /

+0.645 (+6.13%)

MDRX Allscripts
$11.16 /

+0.645 (+6.13%)

Recommendations
Bellway price target raised to 2,910 GBp from 2,720 GBp at JPMorgan » 12:08
10/21/20
10/21
12:08
10/21/20
12:08
BLWYF

Bellway

$0.00 /

+ (+0.00%)

JPMorgan analyst Rajesh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLWYF Bellway
$0.00 /

+ (+0.00%)

11:49 Today Citi
Bellway price target raised to 3,440 GBp at Citi
10/08/20 Barclays
Bellway initiated with an Equal Weight at Barclays
06/26/20 Jefferies
Bellway price target lowered to 3,444 GBp from 3,800 GBp at Jefferies
03/31/20 JPMorgan
Bellway price target lowered to 2,740 GBp from 4,890 GBp at JPMorgan
Syndicate
Datto opens at $32, IPO priced at $27 per share  12:06
10/21/20
10/21
12:06
10/21/20
12:06
MSP

Datto

$11.45 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 21
    Oct
On The Fly
Fly Intel: What to watch in Tesla earnings report » 12:05
10/21/20
10/21
12:05
10/21/20
12:05
TSLA

Tesla

$431.48 /

+9.51 (+2.25%)

, PCRFY

Panasonic

$0.00 /

+ (+0.00%)

Tesla (TSLA) is expected…

ShowHide Related Items >><<
TSLA Tesla
$431.48 /

+9.51 (+2.25%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$431.48 /

+9.51 (+2.25%)

10/19/20 Wedbush
Tesla price target raised to $500 from $475 at Wedbush
10/16/20 Morgan Stanley
Tesla price target raised to $333 from $272 at Morgan Stanley
10/14/20 Credit Suisse
Q3 beat could be positive catalyst for Tesla stock, says Credit Suisse
10/14/20 JPMorgan
NIO Inc. upgraded to Overweight from Neutral at JPMorgan
PCRFY Panasonic
$0.00 /

+ (+0.00%)

09/23/20 Jefferies
Panasonic downgraded to Underperform ahead of Tesla event at Jefferies
09/22/20 Jefferies
Panasonic downgraded to Underperform from Hold at Jefferies
04/22/20 UBS
Panasonic downgraded to Sell from Neutral at UBS
03/16/20 Citi
Panasonic upgraded to Buy from Neutral at Citi
TSLA Tesla
$431.48 /

+9.51 (+2.25%)

  • 14
    Feb
TSLA Tesla
$431.48 /

+9.51 (+2.25%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$431.48 /

+9.51 (+2.25%)

PCRFY Panasonic
$0.00 /

+ (+0.00%)

TSLA Tesla
$431.48 /

+9.51 (+2.25%)

Earnings
Continental AG reports preliminary Q3 consolidated sales of EUR 10.3B » 12:05
10/21/20
10/21
12:05
10/21/20
12:05
CTTAY

Continental AG

$0.00 /

+ (+0.00%)

Continental AG announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTTAY Continental AG
$0.00 /

+ (+0.00%)

11:52 Today Berenberg
Continental AG price target raised to EUR 103 from EUR 95 at Berenberg
10/16/20 HSBC
HSBC upgrades Continental AG to Buy ahead of investor meetings
10/16/20 HSBC
Continental AG upgraded to Buy from Hold at HSBC
10/14/20 Deutsche Bank
Continental AG price target raised to EUR 100 from EUR 70 at Deutsche Bank
CTTAY Continental AG
$0.00 /

+ (+0.00%)

Options
Sabre call volume above normal and directionally bullish » 12:05
10/21/20
10/21
12:05
10/21/20
12:05
SABR

Sabre

$6.64 /

-0.19 (-2.78%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SABR Sabre
$6.64 /

-0.19 (-2.78%)

SABR Sabre
$6.64 /

-0.19 (-2.78%)

09/28/20 Deutsche Bank
Sabre long-term risk/reward looks favorable, says Deutsche Bank
05/11/20 Bernstein
Bernstein upgrades Sabre to Outperform ahead of air travel returning
05/11/20
Sabre upgraded to Outperform from Market Perform at Bernstein
04/13/20 Mizuho
Sabre price target raised to $5 from $3 at Mizuho
SABR Sabre
$6.64 /

-0.19 (-2.78%)

  • 20
    Aug
SABR Sabre
$6.64 /

-0.19 (-2.78%)

SABR Sabre
$6.64 /

-0.19 (-2.78%)

Syndicate
MingZhu Logistics opens for trade at $4.40, IPO priced at $4 » 12:03
10/21/20
10/21
12:03
10/21/20
12:03
YGMZ

MingZhu Logistics

$0.00 /

+ (+0.00%)

MingZhu Logistics, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Natuzzi falls -17.6% » 12:00
10/21/20
10/21
12:00
10/21/20
12:00
NTZ

Natuzzi

$6.21 /

-1.14 (-15.51%)

Natuzzi is down -17.6%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTZ Natuzzi
$6.21 /

-1.14 (-15.51%)

Hot Stocks
GSX Techedu falls -27.4% » 12:00
10/21/20
10/21
12:00
10/21/20
12:00
GSX

GSX Techedu

$74.52 /

-28.405 (-27.60%)

GSX Techedu is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSX GSX Techedu
$74.52 /

-28.405 (-27.60%)

GSX GSX Techedu
$74.52 /

-28.405 (-27.60%)

09:54 Today
Fly Intel: Top five analyst downgrades
08:56 Today Credit Suisse
GSX Techedu downgraded to Underperform from Neutral at Credit Suisse
08/31/20 JPMorgan
GSX Techedu price target raised to $75 from $43 at JPMorgan
08/10/20 Citi
GSX Techedu downgraded to Sell from Buy at Citi
GSX GSX Techedu
$74.52 /

-28.405 (-27.60%)

  • 21
    Nov
GSX GSX Techedu
$74.52 /

-28.405 (-27.60%)

GSX GSX Techedu
$74.52 /

-28.405 (-27.60%)

GSX GSX Techedu
$74.52 /

-28.405 (-27.60%)

Hot Stocks
Armstrong Flooring falls -28.0% » 12:00
10/21/20
10/21
12:00
10/21/20
12:00
AFI

Armstrong Flooring

$3.75 /

-1.52 (-28.84%)

Armstrong Flooring is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFI Armstrong Flooring
$3.75 /

-1.52 (-28.84%)

AFI Armstrong Flooring
$3.75 /

-1.52 (-28.84%)

05/14/20
Fly Intel: Top five analyst upgrades
05/14/20 Nomura Instinet
Nomura upgrades Armstrong Flooring to Buy, sees 120% potential upside
05/14/20 Nomura Instinet
Armstrong Flooring upgraded to Buy from Neutral at Nomura Instinet
03/10/20 Nomura Instinet
Armstrong Flooring price target lowered to $2 from $3 at Nomura Instinet
AFI Armstrong Flooring
$3.75 /

-1.52 (-28.84%)

AFI Armstrong Flooring
$3.75 /

-1.52 (-28.84%)

Hot Stocks
Haemonetics rises 11.8% » 12:00
10/21/20
10/21
12:00
10/21/20
12:00
HAE

Haemonetics

$105.69 /

+10.99 (+11.61%)

Haemonetics is up 11.8%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$105.69 /

+10.99 (+11.61%)

HAE Haemonetics
$105.69 /

+10.99 (+11.61%)

07/01/20 Raymond James
Haemonetics price target lowered to $113 from $125 at Raymond James
05/06/20 Barrington
Haemonetics downgraded to Market Perform from Outperform at Barrington
04/07/20 Raymond James
Haemonetics price target lowered to $130 from $150 at Raymond James
03/20/20 Jefferies
Haemonetics 'key strategic provider' for plasma COVID approaches, says Jefferies
HAE Haemonetics
$105.69 /

+10.99 (+11.61%)

Hot Stocks
Calix rises 26.7% » 12:00
10/21/20
10/21
12:00
10/21/20
12:00
CALX

Calix

$26.59 /

+5.47 (+25.90%)

Calix is up 26.7%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CALX Calix
$26.59 /

+5.47 (+25.90%)

CALX Calix
$26.59 /

+5.47 (+25.90%)

10/16/20 Jefferies
Calix price target raised to $30 from $25 at Jefferies
10/14/20 Needham
Calix initiated with a Buy at Needham
07/23/20 Jefferies
Jefferies boosts Calix target to $25, says not too late to buy shares
07/23/20 Craig-Hallum
Calix price target raised to $25 from $14 at Craig-Hallum
CALX Calix
$26.59 /

+5.47 (+25.90%)

  • 30
    Jul
  • 27
    Feb
CALX Calix
$26.59 /

+5.47 (+25.90%)

Hot Stocks
Snap rises 35.0% » 12:00
10/21/20
10/21
12:00
10/21/20
12:00
SNAP

Snap

$38.41 /

+9.97 (+35.06%)

Snap is up 35.0%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$38.41 /

+9.97 (+35.06%)

SNAP Snap
$38.41 /

+9.97 (+35.06%)

09:54 Today
Fly Intel: Top five analyst upgrades
09:23 Today MKM Partners
Snap price target raised to $40 from $29 at MKM Partners
09:10 Today RBC Capital
Snap price target raised to $45 from $28 at RBC Capital
08:51 Today Truist
Snap upgraded to Buy from Hold at Truist
SNAP Snap
$38.41 /

+9.97 (+35.06%)

SNAP Snap
$38.41 /

+9.97 (+35.06%)

SNAP Snap
$38.41 /

+9.97 (+35.06%)

SNAP Snap
$38.41 /

+9.97 (+35.06%)

Recommendations
Stabilus price target raised to EUR 68 from EUR 58 at Berenberg » 11:58
10/21/20
10/21
11:58
10/21/20
11:58
SBLUY

Stabilus

$0.00 /

+ (+0.00%)

Berenberg analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBLUY Stabilus
$0.00 /

+ (+0.00%)

10/15/20 UBS
Stabilus price target raised to EUR 63 from EUR 53 at UBS
10/07/20 Societe Generale
Stabilus price target raised to EUR 55 from EUR 48 at Societe Generale
07/15/20 JPMorgan
Stabilus price target raised to EUR 45 from EUR 35 at JPMorgan
03/19/20 UBS
Stabilus price target lowered to EUR 55 from EUR 68 at UBS
Recommendations
Serco Group price target raised to 195 GBp from 190 GBp at Berenberg » 11:57
10/21/20
10/21
11:57
10/21/20
11:57
SECCF

Serco Group

$0.00 /

+ (+0.00%)

Berenberg analyst Cormac…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SECCF Serco Group
$0.00 /

+ (+0.00%)

10/16/20 UBS
Serco Group price target lowered to 165 GBp from 180 GBp at UBS
08/17/20 Berenberg
Serco Group price target lowered to 190 GBp from 195 GBp at Berenberg
08/07/20 JPMorgan
Serco Group price target raised to 180 GBp from 170 GBp at JPMorgan
08/07/20 RBC Capital
Serco Group price target lowered to 180 GBp from 185 GBp at RBC Capital
Recommendations
Schaeffler AG price target lowered to EUR 7 from EUR 7.40 at Berenberg » 11:56
10/21/20
10/21
11:56
10/21/20
11:56
SCFLF

Schaeffler AG

$0.00 /

+ (+0.00%)

Berenberg analyst Romain…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCFLF Schaeffler AG
$0.00 /

+ (+0.00%)

10/15/20 UBS
Schaeffler AG price target lowered to EUR 6 from EUR 7 at UBS
09/11/20 DZ Bank
Schaeffler AG downgraded to Hold from Buy at DZ Bank
09/10/20 Berenberg
Schaeffler AG initiated with a Buy at Berenberg
07/07/20 DZ Bank
Schaeffler AG upgraded to Buy from Hold at DZ Bank
Recommendations
Gamesys Group price target raised to 1,450 GBp from 1,300 GBp at Berenberg » 11:55
10/21/20
10/21
11:55
10/21/20
11:55
JKPTF

Gamesys Group

$0.00 /

+ (+0.00%)

Berenberg analyst Jack…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JKPTF Gamesys Group
$0.00 /

+ (+0.00%)

11:20 Today Deutsche Bank
Gamesys Group price target raised to 1,500 GBp from 1,260 GBp at Deutsche Bank
10/05/20 Deutsche Bank
Gamesys Group named short-term investment idea at Deutsche Bank
Recommendations
Demant price target raised to DKK 198 from DKK 190 at Berenberg » 11:54
10/21/20
10/21
11:54
10/21/20
11:54
WILYY

Demant

$0.00 /

+ (+0.00%)

Berenberg analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WILYY Demant
$0.00 /

+ (+0.00%)

08/05/20 Credit Suisse
Demant downgraded to Underperform from Neutral at Credit Suisse
06/23/20 JPMorgan
Demant price target raised to DKK 196 from DKK 145.80 at JPMorgan
06/17/20 Berenberg
Demant downgraded to Hold from Buy at Berenberg
05/22/20 UBS
Demant price target lowered to DKK 185 from DKK 230 at UBS
Recommendations
Danone price target lowered to EUR 59 from EUR 61.50 at Berenberg » 11:53
10/21/20
10/21
11:53
10/21/20
11:53
DANOY

Danone

$0.00 /

+ (+0.00%)

Berenberg analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DANOY Danone
$0.00 /

+ (+0.00%)

DANOY Danone
$0.00 /

+ (+0.00%)

10/20/20 Barclays
Danone price target lowered to EUR 65 from EUR 70 at Barclays
10/20/20 RBC Capital
Danone price target lowered to EUR 63 from EUR 70 at RBC Capital
10/12/20 Bernstein
Danone initiated with an Underperform at Bernstein
08/07/20 Deutsche Bank
Danone downgraded to Hold from Buy at Deutsche Bank
DANOY Danone
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.